EP3846875A4 - System und verfahren zur entfernung von immuninhibitoren aus biologischen flüssigkeiten - Google Patents

System und verfahren zur entfernung von immuninhibitoren aus biologischen flüssigkeiten Download PDF

Info

Publication number
EP3846875A4
EP3846875A4 EP19920634.3A EP19920634A EP3846875A4 EP 3846875 A4 EP3846875 A4 EP 3846875A4 EP 19920634 A EP19920634 A EP 19920634A EP 3846875 A4 EP3846875 A4 EP 3846875A4
Authority
EP
European Patent Office
Prior art keywords
elimination
biological fluids
immune inhibitors
immune
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920634.3A
Other languages
English (en)
French (fr)
Other versions
EP3846875A1 (de
Inventor
Steven Josephs
Matthew Ong
Amir Jafri
Robert Segal
Stephen Prince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunicom Inc
Original Assignee
Immunicom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunicom Inc filed Critical Immunicom Inc
Publication of EP3846875A1 publication Critical patent/EP3846875A1/de
Publication of EP3846875A4 publication Critical patent/EP3846875A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • External Artificial Organs (AREA)
EP19920634.3A 2019-11-19 2019-11-19 System und verfahren zur entfernung von immuninhibitoren aus biologischen flüssigkeiten Withdrawn EP3846875A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/062177 WO2021101519A1 (en) 2019-11-19 2019-11-19 System and method for removal of immune inhibitors from biological fluids

Publications (2)

Publication Number Publication Date
EP3846875A1 EP3846875A1 (de) 2021-07-14
EP3846875A4 true EP3846875A4 (de) 2021-07-14

Family

ID=75980821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920634.3A Withdrawn EP3846875A4 (de) 2019-11-19 2019-11-19 System und verfahren zur entfernung von immuninhibitoren aus biologischen flüssigkeiten

Country Status (8)

Country Link
EP (1) EP3846875A4 (de)
JP (2) JP7159493B2 (de)
KR (2) KR102491518B1 (de)
CN (1) CN114650852B (de)
AU (3) AU2019474912B2 (de)
CA (2) CA3153685C (de)
IL (2) IL301912A (de)
WO (1) WO2021101519A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
WO2022071960A1 (en) * 2020-10-01 2022-04-07 Immunicom, Inc. Reduced leaching of a ligand
JP7632141B2 (ja) * 2021-07-14 2025-02-19 東レ株式会社 モジュール

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (en) * 2016-07-28 2018-02-01 Captec Medical Kft. Flow capture device and method for removing cells from blood
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases
WO2019167048A1 (en) * 2018-02-28 2019-09-06 Plas-free Ltd. Extracorporeal device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213079C (en) 1995-02-16 2004-12-14 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for tumor necrosis factor .alpha., method of removal by adsorption, and adsorption device using said adsorbent
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
JP4150838B2 (ja) * 1999-11-02 2008-09-17 株式会社カネカ 充填物流出防止用フィルタ及びそれを装着した吸着器
WO2004064608A2 (en) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
JP2006288571A (ja) 2005-04-08 2006-10-26 Toray Ind Inc 癌治療用吸着材および体外循環カラム
JP4925159B2 (ja) * 2005-10-12 2012-04-25 日機装株式会社 血液浄化装置
DK3789056T3 (da) * 2007-08-31 2025-06-23 Seastar Medical Inc Indretninger til selektiv cytoferese
JP2009178523A (ja) 2008-02-01 2009-08-13 Kaneka Corp 可溶性腫瘍壊死因子受容体の吸着材、吸着方法および吸着装置
JP5341559B2 (ja) 2009-03-03 2013-11-13 和雄 寺本 多孔性吸着材
US9717841B2 (en) * 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
US20170014450A1 (en) 2014-02-28 2017-01-19 Exosome Sciences, Inc. Brain specific exosome based diagnostics and extracorporeal therapies
JP6480447B2 (ja) * 2014-07-22 2019-03-13 旭化成メディカル株式会社 ヒストンを除去する吸着材及び生体由来液浄化デバイス
JP2018509994A (ja) 2015-03-27 2018-04-12 エリアス・セラピューティクス・インコーポレイテッドＥｌｉａｚ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 患者選択的アフェレシス
DE102018104177A1 (de) * 2018-02-23 2019-08-29 B. Braun Avitum Ag Vorrichtung zur Entfernung von Noxen aus Blut, extrakorporales Perfusionssystem mit einer solchen Vorrichtung sowie Verfahren zur Herstellung einer solchen Vorrichtung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (en) * 2016-07-28 2018-02-01 Captec Medical Kft. Flow capture device and method for removing cells from blood
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases
WO2019167048A1 (en) * 2018-02-28 2019-09-06 Plas-free Ltd. Extracorporeal device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021101519A1 *

Also Published As

Publication number Publication date
EP3846875A1 (de) 2021-07-14
JP2023015053A (ja) 2023-01-31
CA3165330A1 (en) 2021-05-27
IL289438B2 (en) 2023-09-01
CN114650852B (zh) 2024-08-06
AU2019474912B2 (en) 2022-02-17
JP7159493B2 (ja) 2022-10-24
AU2022203249A1 (en) 2022-06-23
CA3153685A1 (en) 2021-05-27
AU2019474912A1 (en) 2022-01-06
KR20220039724A (ko) 2022-03-29
KR20230016032A (ko) 2023-01-31
AU2023274130A1 (en) 2023-12-21
JP7514281B2 (ja) 2024-07-10
CA3153685C (en) 2022-10-11
CN114650852A (zh) 2022-06-21
IL301912A (en) 2023-06-01
IL289438B1 (en) 2023-05-01
KR102491518B1 (ko) 2023-01-20
IL289438A (en) 2022-02-01
JP2022535604A (ja) 2022-08-09
WO2021101519A1 (en) 2021-05-27
AU2022203249B2 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
EP3948772A4 (de) Verfahren und system zur selektion von embryonen
EP3610450A4 (de) System und verfahren zur parallelverarbeitung von blockkettentransaktionen
EP4038374A4 (de) System und verfahren zur ai-sichtprüfung
EP3821313A4 (de) System und verfahren zur identifizierung und sammlung von objekten
EP3776194A4 (de) Verfahren und system zur verbesserung der leistung und isolation eines softwarebehälters
EP3846875A4 (de) System und verfahren zur entfernung von immuninhibitoren aus biologischen flüssigkeiten
EP3822630C0 (de) Verfahren und vorrichtung zur trennung biologischer entitäten
EP3680910A4 (de) System und verfahren zur übertragung von elektronischen rezepten auf der basis von cloud-computing
EP3876495A4 (de) Verfahren und vorrichtung zum betrieb einer internet-of-things-vorrichtung
EP3926902A4 (de) Verfahren und system zur datenübertragung im internet der dinge
EP3789751A4 (de) Verfahren und system zur bestimmung der thrombozytenkonzentration
EP3820588A4 (de) System und verfahren zur verarbeitung schwimmfähiger partikel
EP4208850A4 (de) System und verfahren für virtuelle pankreatographie-pipeline
EP3803049A4 (de) Verfahren und system zur abschwächung des haftgleiteffekts
EP3823561A4 (de) System und verfahren zur knochenfusion
EP3626574A4 (de) Verfahren und system zur messung des zugradstands
EP3799661A4 (de) Verfahren und system zur absoluten positionierung eines objekts
EP3776469A4 (de) System und verfahren zur 3d-assoziierung von erfassten objekten
EP3843793A4 (de) System und verfahren zur verringerung von mikroorganismen
EP4094120A4 (de) System und verfahren zur verbesserung der sehschärfe
EP3652761A4 (de) System und verfahren zur bestimmung des alters eines transformators
EP4225025A4 (de) System und verfahren zur garnelenkultivierung
EP3773186A4 (de) Verfahren und system zur beurteilung eines blutflusses
EP3746909A4 (de) System und verfahren für domänenassistent
EP4196056A4 (de) System und verfahren zur behandlung und prävention von periprothetischen gelenkinfektionen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17P Request for examination filed

Effective date: 20200929

A4 Supplementary search report drawn up and despatched

Effective date: 20210401

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20210625

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250603